2019 Conference




The 17th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place at the Steigenberger Airport Hotel on the 13–14 May 2019.

The 2019 IOTOD Scientific Committee headed-up the two-day meeting, with international experts invited to speak on topics such as opioid analgesic dependence (OAD), abstinence-based pathways, overdose prevention, and HIV and HCV.

The webcasts from this year’s conference are available to view below

STRATEGIES FOR EVOLVING POPULATIONS: MAXIMISING NEW APPROACHES AND SHARPENING OLD TOOLS

AT THE FOREFRONT OF TREATMENT: CHALLENGES AND INNOVATIONS

TIME TO ACT: REVOLUTIONISING OVERDOSE PREVENTION STRATEGIES

HIV AND HCV: HOW FAR HAVE WE COME AND WHERE ARE WE GOING? supported by Gilead Sciences

COMPLEX CASES: PANEL DISCUSSION

*The IOTOD educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and conference organiser.

Scientific Committee

Mr Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

Glasgow, Scotland

Professor Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Professor Jens Reimer

University Medical Center Hamburg

Hamburg, Germany

Dr Elisabeth Avril

Gaia Paris

Paris, France

Gold Sponsors

Camurus

Gilead Sciences

AbbVie

Other Supporters

Althea







Reports

Achieving HCV elimination
Hepatitis C Virus (HCV) Complexities and comorbidities in HCV care
View all reports